Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
作者信息
Klubes P, Miller H G, Cerna I, Trevithick J
出版信息
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1901-7.
PMID:526922
Abstract
摘要
相似文献
1
Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.在使用苯巴比妥或SKF 525A预处理后，小鼠体内甲基环己亚硝脲的毒性和抗肿瘤活性的变化。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1901-7.
2
Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.苯巴比妥或SKF 525A预处理对洛莫司汀毒性和抗肿瘤活性的影响。
Cancer Treat Rep. 1983 Mar;67(3):259-65.
3
Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.使用氯丙嗪和咖啡因增强亚硝基脲对小鼠肿瘤的治疗作用。
Cancer Treat Rep. 1978 Dec;62(12):2085-93.
4
Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.氯脲霉素。小鼠骨髓毒性降低的机制。
J Clin Invest. 1979 Oct;64(4):1103-11. doi: 10.1172/JCI109549.
5
Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.
Cancer Treat Rep. 1977 May-Jun;61(3):409-17.
6
Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.小麦黄素D与苯巴比妥、3-甲基胆蒽及SKF-525A在小鼠体内的相互作用。
J Toxicol Environ Health. 1983 Oct-Dec;12(4-6):687-94. doi: 10.1080/15287398309530460.
7
Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Cancer Res. 1978 Apr;38(4):1070-4.
8
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.新型亚硝基脲类抗肿瘤药物氯脲霉素（Nsc - 178248）的药理学
Cancer Treat Rep. 1976 Jun;60(6):801-5.
9
Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU).
Cancer Clin Trials. 1978 Summer;1(2):99-102.
10
Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.氟尿嘧啶和司莫司汀用于晚期结直肠癌的I-II期研究。
Cancer. 1979 Sep;44(3):869-72. doi: 10.1002/1097-0142(197909)44:3<869::aid-cncr2820440312>3.0.co;2-f.
引用本文的文献
1
Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.亲电子药物增强洛莫司汀抗肿瘤作用的构效关系
Br J Cancer. 1982 Aug;46(2):249-59. doi: 10.1038/bjc.1982.190.
2
Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. II. Biochemical and morphological characterization of the injury and its prevention by phenobarbital.1-（2-氯乙基）-3-环己基-1-亚硝基脲（CCNU）诱导肝毒性的机制研究。II. 损伤的生化和形态学特征以及苯巴比妥对其的预防作用
Cancer Chemother Pharmacol. 1987;19(2):103-8. doi: 10.1007/BF00254560.
3
H2-antagonists and carmustine.H2拮抗剂与卡莫司汀。
J Cancer Res Clin Oncol. 1989;115(1):41-6. doi: 10.1007/BF00391598.
Zotero 插件